Answers are grounded in this paper and cite their sources.
African-American patients with breast carcinomas are more likely than Caucasian patients to present with tumors that are of a later stage and higher grade, with higher Ki-67 expression and more ER negativity, thereby highlighting a greater need for early screening among African-American women. Molecular studies that may explain these differences, and correlations with survival, have been proposed to identify therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Morris et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: